{"disease":{"id":"ipf","name":"ipf"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07178392","title":"Disease-syndrome Characteristics of IPF","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2864,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT02758808","title":"Pulmonary Fibrosis Foundation Patient Registry","phase":"","overall_status":"COMPLETED","enrollment_count":2004,"lead_sponsor_name":"Pulmonary Fibrosis Foundation","has_results":false},{"nct_id":"NCT04503044","title":"ILAs in CT Lung Cancer Screening Population","phase":"","overall_status":"COMPLETED","enrollment_count":1703,"lead_sponsor_name":"Lahey Clinic","has_results":false},{"nct_id":"NCT07162870","title":"Idiopathic Pulmonary Fibrosis Cohort of TCM","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03478553","title":"The Genetics of Pulmonary Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03211507","title":"Idiopathic Pulmonary Fibrosis Job Exposures Study","phase":"","overall_status":"COMPLETED","enrollment_count":960,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT04564183","title":"Advancing Prevention of Pulmonary Fibrosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04263727","title":"A Study of Patients With Chronic Disease","phase":"","overall_status":"TERMINATED","enrollment_count":579,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT07464912","title":"A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":508,"lead_sponsor_name":"Beijing Tide Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT07082842","title":"Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":472,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT06644144","title":"P4O2 ILD Extension","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT07519070","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":420,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06914713","title":"Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":384,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06951217","title":"An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Avalyn Pharma Inc.","has_results":false},{"nct_id":"NCT06922916","title":"Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT05147597","title":"Turkish Validity and Reliability of SGRQ-I","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT03832946","title":"A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Galecto Biotech AB","has_results":true},{"nct_id":"NCT07139925","title":"Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":156,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06650774","title":"Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Karadeniz Technical University","has_results":false},{"nct_id":"NCT07486206","title":"Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT07169253","title":"Prognostic Score Comparison in IPF and HP","phase":"","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT07179562","title":"Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06968845","title":"A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Rein Therapeutics","has_results":false},{"nct_id":"NCT07019090","title":"Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06909409","title":"D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03864328","title":"A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":108,"lead_sponsor_name":"Respivant Sciences GmbH","has_results":false},{"nct_id":"NCT07466420","title":"Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Katerina M. Antoniou","has_results":false},{"nct_id":"NCT03873298","title":"Inhaled NO in IPF and COPD During 6 Minute Walk Test","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT06714812","title":"Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07493031","title":"A PhaseⅠ Study of HW252001 in Healthy Subjects","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":98,"lead_sponsor_name":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.","has_results":false},{"nct_id":"NCT07447102","title":"Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Dragonboat Biopharmaceutical Company Limited","has_results":false},{"nct_id":"NCT07482917","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT03650075","title":"To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Metagone Biotech Inc.","has_results":false},{"nct_id":"NCT04589260","title":"TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":72,"lead_sponsor_name":"Theravance Biopharma","has_results":false},{"nct_id":"NCT05938920","title":"Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"InSilico Medicine Hong Kong Limited","has_results":true},{"nct_id":"NCT06615128","title":"Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06310746","title":"A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT07131150","title":"Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07178197","title":"Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Mersin University","has_results":false},{"nct_id":"NCT06636487","title":"Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT07031362","title":"The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Izmir Katip Celebi University","has_results":false},{"nct_id":"NCT04598919","title":"Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":49,"lead_sponsor_name":"National Jewish Health","has_results":false},{"nct_id":"NCT05570058","title":"Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Redx Pharma Ltd","has_results":false},{"nct_id":"NCT07121413","title":"A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Shanghai Synvida Biotechnology Co.,Ltd.","has_results":false},{"nct_id":"NCT05190211","title":"Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"Istanbul Medipol University Hospital","has_results":false},{"nct_id":"NCT01371305","title":"STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT03619616","title":"Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Guangdong Zhongsheng Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05975983","title":"Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"InSilico Medicine Hong Kong Limited","has_results":false},{"nct_id":"NCT06331624","title":"Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"GRI Bio Operations, Inc.","has_results":false},{"nct_id":"NCT06756230","title":"Downhill Walking in IPF","phase":"NA","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}